Three-Statement Breakdown
REVENUE UP
Revenue rose 2.5% year over year to $138.2B, and carried a 12.4% net margin.
REVENUE
+2.5%
138,191
GROSS PROFIT
—
—
NET INCOME
-1.9%
17,174
EPS (DILUTED)
-1.9%
$4.06
| Income statement | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
|
130,863 | 131,868 | 128,292 | 133,613 | 136,835 | 133,974 | 134,788 | 138,191 | +2.5% |
| SG&A |
|
(31,083) | (29,896) | (31,573) | (28,658) | (30,136) | (32,745) | (34,113) | (33,818) | -0.9% |
| Operating income |
|
22,278 | 30,378 | 28,798 | 32,448 | 30,467 | 22,877 | 28,686 | 29,259 | +2.0% |
| Interest expense |
|
(4,833) | (4,730) | (4,247) | (3,485) | (3,613) | (5,524) | (6,649) | (6,694) | +0.7% |
| Income tax |
|
(3,584) | (2,945) | (5,619) | (6,802) | (6,523) | (4,892) | (5,030) | (5,064) | +0.7% |
| Net income |
|
15,528 | 19,265 | 17,801 | 22,065 | 21,256 | 11,614 | 17,506 | 17,174 | -1.9% |
| EPS (diluted) |
|
$3.76 | $4.65 | $4.30 | $5.32 | $5.06 | $2.75 | $4.14 | $4.06 | -1.9% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-31 ↗